Echo Therapeutics is an Australian Pharmaceutical and Medical Technology Company, specialising in branded products and unique services for the hospital sector in Australia and New Zealand.

Echo Therapeutics

Echo Therapeutics ANZ | 363 followers on LinkedIn. Partnering for success: Multinational quality, boutique service for patients, payers and partners | Echo Therapeutics is a newly-formed Australian pharmaceutical and medical technology company for the ANZ hospital sector. 

Realising untapped value for you by connecting patient insights to your needs.

Having a meaningful impact on patients’ lives by partnering with global and local groups, we will “echo” their brands in our markets to build value for our customers to enable a better patient experience.

Medical Manager at Echo Therapeutics ANZ

Erik Teh

Echo Therapeutics ANZ

A single spark can ignite a flame of change – and Echo Therapeutics is proud to be part of that spark! Echo Therapeutics ANZ is thrilled to announce that we'll be part of the Advanced Pharmacy Australia - Medicines Management 2024 Conference in Adelaide beginning today. Visit the team at Stand 12 in the exhibition hall to connect, collaborate, and join us on the mission to illuminate new ways of thinking in pharma. 🙏 https://lnkd.in/gZ2mAhvF #Pharmacy #hospital #partnerships #collaboration #echotherapeuticsanz

Reposting this to our LinkedIn Echo Therapeutics ANZ friends to see if anyone that is available to lend a hand to Chronic Pain Australia and volunteer in the Lismore NSW region 🤝 see the post below for more info..

The Echo Therapeutics ANZ team was delighted to attend the #2024 Australian Society of Anaesthetists ' National Scientific Conference in Darwin last week, to connect and reconnect with delegates from the #ASA . It was great to attend the #ASA plenary and sessions on the management of acute pain and hear from delegates about their real-world challenges, and their commitment to supporting responsible pain management post surgery. The team also had some opportunities to meet some 'locals' and enjoy some team downtime as well. Echo Therapeutics ANZ #ASA

Echo Therapeutics ANZ was proud to host the Cancer Council Australia initiative for Australia's Biggest Morning Tea event yesterday! The annual event raises awareness on the impact of cancer research, support, and prevention. One in two of us will have a cancer diagnosis by 85 years. Every one of us has been touched directly or by someone we know with a cancer diagnosis. As an ex-oncology nurse this is very important to me personally. We were joined by the #Echo team, family, friends and dignitaries like the Federal member for Bradfield Senator Paul Fletcher and my friend and ex-colleague Medical Oncologist Dr David Bell. Echo Therapeutics products have treated >250,000 cancer patients in the last year alone, across cancer areas including: breast; bowel; lymphomas and myeloproliferative neoplasms. Every contribution makes a difference, and with our target initially set at $1,000, we managed to raise over $3,000. If you would like to contribute to this worthy cause, feel free to donate at @ https://lnkd.in/gqYYJfAr

Echo Therapeutics ANZ is delighted to announce our new strategic partnership 🤝 with Pharmanovia , to promote its Pain/CNS portfolio and selected products within the endocrinology portfolio. Dimitri Pimbert , Pharmanovia’s V-P, Asia Pacific Region states; “A critical component of our strategy is partnering with like-minded companies who share our purpose and commitment to ensure our medicines get to the patients who need them. That’s why we selected Echo Therapeutics as our partner of choice.” Jude D'Silva D’Silva, Echo Therapeutics ANZ MD added: “This is an important milestone for us. We specialise in promoting important #legacy brands and the #Pharmanovia pain portfolio complements our growing focus on responsible education in managing various types of pain”. “Echo Therapeutics is committed to engaging all its commercial, professional and patient know-how to ensure that Echo’s cross functional teams are able to not only support patients and healthcare professionals, but also to help deliver on business and commercial objectives.” Read the release here👇 #Pharmanovia #EchoTherapeutics #Strategicpartnership #Establishedbrandsgrowth #hospitalpharmaceutical #legacybrands #patientcare

Domain Not Resolving

Gravity Forms

James F. Smith

Vincent D. Enright

David Walton

Vice President, Marketing & Commercial Development

Patrick Mooney

Founder & CEO

Dan Sunday

Vice President, Manufacturing & Global Supply Chain

Scott W. Hollander

President & CEO

Alan Schoenbart

Chief Executive Officer, Chief Financial Officer & Finance

Great Lakes Companies With Less Than $1B in Revenue (Top 10K)

Philadelphia Companies With Fewer Than 100 Employees

Biotechnology Public Companies With Fewer Than 50 Employees

Pennsylvania Companies With Less Than $50M in Revenue (Top 10K)

Echo Therapeutics is a medical device company with deep expertise in advanced skin permeation technology. Echo is developing its Symphony® CGM System as a non-invasive, wireless, continuous glucose monitoring system for use in hospital critical care units and for people with diabetes. The Prelude® SkinPrep System, a component of their Symphony CGM System, allows for enhanced skin permeation that will enable extraction of analytes, such as glucose, and transdermal drug delivery.

Post-IPO Debt - Echo Therapeutics

Post-IPO Equity - Echo Therapeutics

Platinum-Montaur Life Sciences

Philadelphia

Pennsylvania

United States

North America

Orthofix has a new CEO

Continuous Glucose Monitoring Devices Market Size ...

Echo Therapeutics beats whistleblower charges

Echo Therapeutics touts win in whistleblower case

Echo Therapeutics faces uncertain future in whistleblower case

Tiger X Medical Inc.

Blood Glucose Monitoring Devices World Market Outlook 2016-2026

Echo Therapeutics, Inc. Announces First Quarter 2016 Financial Results

HTML5

jQuery

GoDaddy

GoDaddy Premium DNS

Google Fonts

Cloudflare CDN

Apache Server

Comodo PositiveSSL Certificates

Wordpress

Vimeo

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 14, 2024 7:10 AM	e8680d64
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 14, 2024 7:10 AM	5b04a54a
crunchbase trigger	general	Nov 14, 2024 7:10 AM	3904a101
crunchbase profile	general	Nov 15, 2024 1:40 AM	ad41d48a
li profile	general	Nov 14, 2024 7:10 AM	b1e3c737
translate crunchbase fundingrounds	general	Nov 15, 2024 2:37 AM	124cc15a
peers	general	Nov 14, 2024 7:10 AM	dde2e236
news basic	general	Nov 14, 2024 7:10 AM	e8b7e678
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM

AU:COM:ECHOTHERAPEUTICS

Echo Therapeutics